
CAS 855300-09-3
:Formel:C12H15NO3
InChl:InChI=1S/C12H15NO3/c1-4-13(3)12(15)16-11-7-5-6-10(8-11)9(2)14/h5-8H,4H2,1-3H3
InChI Key:ABNQSLSOFYAGHU-UHFFFAOYSA-N
SMILES:CCN(C)C(=O)OC1=CC=CC(=C1)C(=O)C
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte gefunden.
Rivastigmine Related Compound D (3-Acetylphenyl ethyl(methyl)carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof, nesoiFormel:C12H15NO3Farbe und Form:White PowderMolekulargewicht:221.105193-Acetylphenyl ethyl(methyl)carbamate
CAS:3-Acetylphenyl ethyl(methyl)carbamateFormel:C12H15NO3Reinheit:98%Molekulargewicht:221.253-Acetylphenyl ethyl(methyl)carbamate
CAS:Formel:C12H15NO3Reinheit:98%Farbe und Form:LiquidMolekulargewicht:221.2524Rivastigmine EP Impurity C (Rivastigmine USP Related Compound D)
CAS:Formel:C12H15NO3Farbe und Form:Off-White Solid (Low M P )Molekulargewicht:221.26Rivastigmine Related Compound D
CAS:3-Acetylphenyl ethyl(methyl)carbamateFormel:C12H15NO3Reinheit:98%Molekulargewicht:221.25Des [3-(1-Dimethylamino)ethyl] 3-Acetyl Rivastigmine
CAS:Kontrolliertes ProduktImpurity Rivastigmine EP Impurity C; USP Related Compound D
Applications Des [3-(1-dimethylamino)ethyl] 3-acetyl Rivastigmine (Rivastigmine EP Impurity C) is a derivative of Rivastigmine (Tartrate: R541000), and acetylcholinesterase inhibitor that is commonly used to treat dementia associated with Parkinson’s disease and Alzheimer’s disease.
References Emre, M., et al.: New. Engl. J. Med., 351, 2509 (2004); Polinsky, R.: Clin. Ther., 20, 634 (1998); Wilkinson, D., et al.: Int. J. Clin. Pract., 56, 441 (2001)Formel:C12H15NO3Farbe und Form:NeatMolekulargewicht:221.253-Acetylphenyl ethyl(methyl)carbamate
CAS:Formel:C12H15NO3Reinheit:98%Farbe und Form:LiquidMolekulargewicht:221.256








